Index of reports
> All Cases (11)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Tasmar (Tolcapone) all cases. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Tasmar side effects in 47 year old male
Reported by a health professional (non-physician/pharmacist) on 2012-08-10
Patient: 47 year old male
Reactions: Volvulus
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Tasmar
Other drugs received by patient: Clozapine; Modopar; Requip
Possible Tasmar side effects in female
Reported by a physician from France on 2012-07-03
Patient: female
Reactions: Kleptomania, Pathological Gambling
Drug(s) suspected as cause:
Madopar
Indication: Parkinson's Disease
Isicom 100
Indication: Parkinson's Disease
Tasmar
Indication: Parkinson's Disease
Neupro Pflaster
Indication: Parkinson's Disease
Other drugs received by patient: PK-Merz 100; Lactulose; Requip
Possible Tasmar side effects in female
Reported by a physician from Germany on 2012-06-26
Patient: female
Reactions: Impulse-Control Disorder, Kleptomania, Pathological Gambling
Drug(s) suspected as cause:
Carbidopa and Levodopa
Dosage: daily dose: 750 mg
Administration route: Oral
Indication: Parkinson's Disease
Neupro
Dosage: 8 mg/24 hour
Indication: Parkinson's Disease
Tasmar
Administration route: Oral
Indication: Parkinson's Disease
Madopar LT
Dosage: 5x1
Administration route: Oral
Indication: Parkinson's Disease
Requip
Dosage: single dose 8
Administration route: Oral
Indication: Parkinson's Disease
Other drugs received by patient: PK-Merz; Lactulose
Possible Tasmar side effects in female
Reported by a physician from Germany on 2012-06-26
Patient: female
Reactions: Impulse-Control Disorder, Kleptomania, Pathological Gambling, Theft
Drug(s) suspected as cause:
Carbidopa and Levodopa
Dosage: 125mg unknown
Administration route: Oral
Indication: Parkinson's Disease
Madopar
Dosage: 125mg five times per day
Administration route: Oral
Indication: Parkinson's Disease
Neupro
Dosage: 8mg per day
Indication: Parkinson's Disease
Requip
Dosage: 8mg three times per day
Administration route: Oral
Indication: Parkinson's Disease
Tasmar
Dosage: 100mg three times per day
Administration route: Oral
Indication: Parkinson's Disease
Other drugs received by patient: Lactulose; L-Dopa; PK-Merz
Possible Tasmar side effects in 71 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-05-11
Patient: 71 year old male
Reactions: Confusional State, Irritability, Abnormal Behaviour, Aggression
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Modopar
Dosage: unknown dose
Administration route: Oral
Tasmar
Administration route: Oral
Indication: Parkinson's Disease
Start date: 2011-12-01
End date: 2012-03-19
Neupro
Dosage: unknown dose
Other drugs received by patient: Acetaminophen
Possible Tasmar side effects in female
Reported by a physician from France on 2012-05-11
Patient: female
Reactions: ON and Off Phenomenon, Dyskinesia, Delirium
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Modopar
Dosage: 125mg five times per day
Administration route: Oral
End date: 2012-01-01
Tasmar
Indication: Product Used FOR Unknown Indication
Azilect
Indication: Product Used FOR Unknown Indication
Requip
Dosage: 24mg per day
Indication: Parkinson's Disease
End date: 2012-01-14
Modopar
Dosage: 250mg per day
Administration route: Oral
End date: 2012-01-01
Modopar
Dosage: 62.5mg in the morning
Administration route: Oral
Indication: Parkinson's Disease
End date: 2012-01-01
Modopar
Dosage: 250mg at night
Administration route: Oral
End date: 2012-01-01
Possible Tasmar side effects in 75 year old male
Reported by a physician from Germany on 2012-04-18
Patient: 75 year old male, weighing 79.0 kg (173.8 pounds)
Reactions: Cardiac Failure, Congestive Cardiomyopathy, Pleural Effusion, Atrial Fibrillation, Generalised Oedema
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Tasmar
Indication: Parkinson's Disease
Start date: 2010-10-07
End date: 2011-12-01
L-Dopa-Retard
Other drugs received by patient: Clarium; Azilect; Madopar; L-Dopa
Possible Tasmar side effects in 75 year old male
Reported by a physician from Germany on 2012-04-18
Patient: 75 year old male, weighing 79.0 kg (173.8 pounds)
Reactions: Cardiac Failure, Atrial Fibrillation, Pleural Effusion, Congestive Cardiomyopathy, Generalised Oedema
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Tasmar
Indication: Parkinson's Disease
Start date: 2010-10-07
End date: 2011-12-01
L-Dopa-Retard
Other drugs received by patient: Madopar; Clarium; L-Dopa; Azilect
Possible Tasmar side effects in male
Reported by a physician from Germany on 2012-03-15
Patient: male
Reactions: Medication Error, Hallucination
Drug(s) suspected as cause:
Tasmar
Administration route: Oral
Rasagiline Mesylate
Administration route: Oral
Requip
Dosage: 6mg twice per day
Administration route: Oral
Indication: Parkinson's Disease
L-Dopa
Administration route: Oral
Possible Tasmar side effects in male
Reported by a consumer/non-health professional from France on 2011-11-25
Patient: male
Reactions: Dystonia, Increased Appetite, Motor Dysfunction, Flight of Ideas, Dyskinesia, Abnormal Behaviour, Akinesia, Paraesthesia, Affective Disorder, Myalgia, Overdose, Insomnia, Pathological Gambling, Treatment Failure, Drug Dependence
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Parlodel
Dosage: 2.5 mg, tid
Administration route: Oral
Indication: Parkinson's Disease
Start date: 1996-10-29
End date: 1997-02-24
Parlodel
Dosage: 5 mg, tid
Administration route: Oral
Start date: 1997-02-25
End date: 1998-10-26
Parlodel
Dosage: 10 mg, qid
Administration route: Oral
Start date: 2000-06-06
End date: 2002-11-14
Pergolide Mesylate
Dosage: 0.25 mg, qid
Administration route: Oral
Start date: 2001-05-16
End date: 2001-05-30
Pergolide Mesylate
Dosage: 1 mg, qid
Administration route: Oral
Start date: 2003-04-29
End date: 2003-10-28
Madopar Dispersible
Dosage: 2 df, qd
Administration route: Oral
Start date: 2000-06-06
End date: 2000-08-02
Madopar Dispersible
Dosage: 1.5 tab twice + 1 tab daily
Administration route: Oral
Start date: 2001-12-01
Madopar Dispersible
Dosage: 3 df, qd
Administration route: Oral
Start date: 2005-06-05
End date: 2006-12-05
Sinemet
Dosage: 7 df, qd
Administration route: Oral
Start date: 2002-11-15
End date: 2003-10-28
Sinemet
Dosage: 5.5 df, qd
Administration route: Oral
Start date: 2001-06-01
End date: 2001-11-28
Madopar
Dosage: 3 df, qd
Administration route: Oral
Start date: 1996-10-29
End date: 1998-09-17
Madopar Dispersible
Dosage: 0.5 df, qd
Administration route: Oral
Start date: 2001-06-01
End date: 2001-11-28
Madopar
Dosage: 2 df, qd
Administration route: Oral
Start date: 1996-10-29
End date: 1998-10-25
Tasmar
Dosage: 3 df, qd
Administration route: Oral
Start date: 1998-10-20
Sinemet
Dosage: 1 df, qd
Administration route: Oral
Start date: 2007-01-30
Sinemet
Dosage: 5.5 tablets daily
Administration route: Oral
Start date: 2002-03-12
End date: 2002-11-14
Sinemet
Dosage: 4.5 tablets daily
Administration route: Oral
Start date: 2002-11-15
Parlodel
Dosage: 50 mg, qd
Administration route: Oral
Start date: 2002-05-27
End date: 2003-04-12
Trivastal
Dosage: 2 df, qd
Administration route: Oral
Start date: 2007-01-30
Madopar
Dosage: 6 df, qd
Administration route: Oral
Start date: 2000-06-06
End date: 2000-08-02
Madopar
Dosage: 1 df, qd
Administration route: Oral
Start date: 2001-11-29
End date: 2003-10-28
Madopar Dispersible
Dosage: 1 df, qd
Administration route: Oral
Start date: 2002-03-03
End date: 2003-04-11
Sinemet
Dosage: 5 df, qd
Administration route: Oral
Start date: 2001-06-01
End date: 2001-11-28
Sinemet
Dosage: 6 df, qd
Administration route: Oral
Start date: 2001-11-29
End date: 2002-11-14
Sinemet
Dosage: 1 df, qd
Administration route: Oral
Start date: 2006-12-06
End date: 2007-01-29
Sinemet
Dosage: 5 df, qd
Administration route: Oral
Start date: 2001-12-12
End date: 2002-03-11
Parlodel
Dosage: 10 mg, bid
Start date: 2002-11-15
Pergolide Mesylate
Dosage: 1 mg, qid
Administration route: Oral
Indication: Parkinson's Disease
Start date: 2001-02-05
End date: 2001-05-15
Madopar Dispersible
Dosage: 0.5 df, qd
Administration route: Oral
Start date: 2006-12-06
End date: 2007-01-29
Madopar Dispersible
Dosage: 2 df, qd
Administration route: Oral
Start date: 2007-03-20
Parlodel
Dosage: 2.5 mg, qid
Administration route: Oral
Start date: 2001-06-01
End date: 2002-08-01
Parlodel
Dosage: 50 mg, qd
Administration route: Oral
Start date: 2000-11-29
End date: 2001-02-05
Pergolide Mesylate
Dosage: 1 mg, tid
Administration route: Oral
Start date: 2003-10-29
Pergolide Mesylate
Dosage: 1 mg, tid
Administration route: Oral
Start date: 2005-06-05
Madopar
Dosage: 5 df, qd
Administration route: Oral
Start date: 1998-10-26
End date: 2000-06-05
Madopar
Dosage: 1
Madopar Dispersible
Dosage: 0.5 df, qid
Administration route: Oral
Start date: 2001-11-29
End date: 2001-12-01
Madopar
Dosage: 2 df, qd
Administration route: Oral
Start date: 1998-10-26
Madopar
Dosage: 5 df, qd
Administration route: Oral
Start date: 2000-08-03
End date: 2001-11-28
Madopar
Dosage: 5 df, qd
Administration route: Oral
Start date: 2003-10-29
End date: 2006-12-05
Madopar
Dosage: 4 df, qd
Administration route: Oral
Start date: 2006-12-06
End date: 2007-03-19
Madopar Dispersible
Dosage: 1 df, qd
Administration route: Oral
Start date: 2000-08-03
End date: 2001-02-04
Madopar Dispersible
Dosage: 1 df, qd
Administration route: Oral
Start date: 2003-10-29
Madopar Dispersible
Dosage: 4 df, qd
Administration route: Oral
Start date: 2007-01-30
End date: 2007-03-19
Tasmar
Dosage: 3 df, qd
Administration route: Oral
Start date: 1998-09-18
End date: 1998-10-19
Sinemet
Dosage: 4 df, qd
Administration route: Oral
Start date: 2001-02-05
End date: 2001-05-31
Sinemet
Dosage: 1 df, qd
Administration route: Oral
Start date: 2003-10-29
Parlodel
Dosage: 5 mg, bid
Administration route: Oral
Start date: 2002-11-15
Parlodel
Dosage: 40 mg
Trivastal
Dosage: 4 df, qd
Administration route: Oral
Indication: Parkinson's Disease
Start date: 2006-06-19
End date: 2007-01-29
Madopar
Dosage: 4 df, qd
Administration route: Oral
Start date: 1998-09-18
End date: 1998-10-25
Madopar
Dosage: 4 df, qd
Administration route: Oral
Start date: 2007-03-20
Madopar Dispersible
Dosage: 0.5 df, qid
Administration route: Oral
Start date: 2001-02-05
End date: 2001-05-31
Madopar Dispersible
Dosage: 1.5 df, 5qd
Administration route: Oral
Start date: 2003-04-12
End date: 2003-10-28
Sinemet
Dosage: 6 df, qd
Administration route: Oral
Start date: 2001-11-29
End date: 2001-12-11
Other drugs received by patient: Amantadine HCL; Lexomil; Huile DE Paraffine; Imovane; Dopa and Dopa Derivatives; Proctolog; Paroxetine HCL; Amantadine HCL; Imovane; Amantadine HCL; Ketoconazole; Proctolog; Comtan; Dopa and Dopa Derivatives; Lexomil; Lexomil; Actapulgite; Lexomil; Motilium
Possible Tasmar side effects in 56 year old
Reported by a consumer/non-health professional from Germany on 2011-10-14
Patient: 56 year old
Reactions: Dyspnoea, Drug Ineffective, Gout, Diplegia, Therapeutic Response Unexpected, Condition Aggravated, Asthenia, Pulmonary Fibrosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neupro
Dosage: 16mg per day
Entacapone
Isicom
Tasmar
Requip
Dosage: 12mg per day
Administration route: Oral
Indication: Parkinson's Disease
|